<DOC>
	<DOCNO>NCT00860652</DOCNO>
	<brief_summary>Radical prostatectomy ( RP ) common curative approach offer men newly diagnose prostate cancer . Unfortunately , half patient factor place high risk cancer recur . Having radiotherapy RP know improve cure rate , know whether give straight operation rise PSA surgery indicate active cancer . Immediate RT may benefit men , cause serious side effect bladder bowel problem impotence . International lack consensus optimal timing RT result varied clinical practice . This phase 3 trial compare two approach .</brief_summary>
	<brief_title>Radiotherapy - Adjuvant Versus Early Salvage</brief_title>
	<detailed_description>This prospective , multi-centre , international , randomise control trial 1:1 allocation ratio . Patients positive margin and/or pT3 disease randomise adjuvant RT ( Standard Arm ) active surveillance salvage RT deliver early relapse ( Experimental Arm ) . 64 Gy 32 fraction deliver prostate bed . QoL self-assessment questionnaire , Hospital Anxiety Depression Score toxicity assess baseline , end RT annually 5 year . Patients see doctor 6 monthly first 5 year , annually next 5 year . A blood test measure prostate specific antigen ( PSA ) do 3 monthly first 5 year patient randomise early salvage RT , 6 monthly year 5 10 .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Prior Radical Prostatectomy ( RP ) adenocarcinoma prostate . Histological confirmation adenocarcinoma prostate Gleason score report ( Radical Prostatectomy specimen ) . Patients must least one follow risk factor : 1 ) Positive margin , 2 ) Extraprostatic extension ( EPE ) without seminal vesicle involvement ( pT3a pT3b ) Capable start RT within 4 month RP ( requirement randomise adjuvant RT arm ) Most recent PSA â‰¤ 0.10 ng/ml follow RP prior randomisation Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 Patient able adhere specify followup schedule complete Quality Life anxiety/depression selfassessments Written inform consent obtain prior randomisation Completion pretreatment evaluation 18 year older Previous pelvic RT Androgen deprivation ( AD ) prior follow RP Evidence nodal distant metastasis Comorbidities would interfere completion treatment and/or 5 year followup Concurrent cytotoxic medication Hip prosthesis</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Oncology</keyword>
	<keyword>Prostate Cancer</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Radical Prostatectomy</keyword>
	<keyword>Prior Radical Prostatectomy ( RP )</keyword>
	<keyword>Histological Confirmation adenocarcinoma prostate</keyword>
	<keyword>Positive margin and/or extraprostatic extension ( EPE )</keyword>
</DOC>